Business Context and Reporting Period
Company: RCM Technologies, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: April 30, 1996
Industry: Staffing services (Information technology and health care personnel).
Key Corporate Actions: The company completed a 1-for-5 reverse stock split and implemented a Shareholder Rights Plan ("Poison Pill") during the period. It also executed two significant acquisitions: The Consortium (March 1996) and The Consortium of Maryland, Inc. (May 1996).
Key Financial Metrics
| Metric | Six Months Ended Apr 30, 1996 |
Six Months Ended Apr 30, 1995 |
|---|---|---|
| Revenues | $23,562,110 | $12,972,928 |
| Net Income | $888,599 | $506,739 |
| Earnings Per Share (EPS) | $0.24 | $0.17 |
| Gross Profit Margin | 18.1% | 17.7% |
| Operating Income | $1,048,865 | $501,056 |
| Cash from Operations | ($366,853) | $632,526 |
| Cash and Equivalents (Ending) | $70,078 | $297,550 |
| Total Debt (Current + Long Term) | $3,191,195 | $1,026,380 |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 81.6% year-over-year, driven primarily by the acquisitions of Cataract, Inc. (1995) and The Consortium (1996).
- Profitability: Net income rose 75.3% to $888,599. Operating income more than doubled (109.3%) due to the ability to spread fixed expenses over a larger revenue base.
- Cash Flow Deterioration: Operating cash flow turned negative ($366,853 outflow) compared to a positive $632,526 in the prior year. This was primarily due to a significant increase in accounts receivable ($1.22 million increase) and changes in accrued payroll.
- Balance Sheet Expansion: Total assets nearly doubled from $10.3 million to $23.0 million. Intangible assets increased significantly to $9.6 million due to acquisition-related goodwill and amortization.
- Debt Increase: Short-term bank borrowings increased by $2.18 million to $3.09 million to fund acquisitions and working capital needs.
Guidance, Outlook, and Risks
- Acquisition Strategy: Management continues to pursue an aggressive acquisition strategy to grow the business. The company is evaluating complementary businesses.
- Liquidity: Despite a drop in cash on hand, the company maintains a $10 million credit facility (increased from $6 million in May 1996) with approximately $2.9 million in availability as of April 30, 1996. Management believes resources are sufficient for the next 12 months.
- Shareholder Rights Plan: A "Poison Pill" plan was adopted, allowing shareholders to purchase shares at $3.00 if any entity acquires 15% or more of the stock. This is a defensive measure against hostile takeovers.
- Contingencies: The acquisition of The Consortium of Maryland, Inc. includes contingent consideration based on tangible net worth, which had not been determined as of the filing date but was expected to be paid by June 15, 1996.
- Risks: The company relies heavily on its credit facility for operations and acquisitions. Future liquidity may be affected by the success of its acquisition integration and the ability to maintain financial ratios required by the bank.
Investor Verification Checklist
- Accounts Receivable Quality: Verify the collectability of the $12 million in accounts receivable, which grew significantly and caused a cash outflow.
- Acquisition Integration: Assess the performance of The Consortium and Consort MD to ensure they are delivering the projected synergies and revenue growth.
- Debt Covenants: Confirm the company is meeting the financial ratio requirements of its $10 million credit facility with Mellon Bank.
- Contingent Liabilities: Monitor the final determination of the tangible net worth for the Consort MD acquisition to understand the final cost of the deal.
- Stock Dilution: Review the impact of the reverse stock split and the issuance of shares for acquisitions on future earnings per share.